Loading...

PT Kalbe Farma Tbk.

PTKFYPNK
Healthcare
Drug Manufacturers - General
$10.25
$-0.24(-2.31%)
U.S. Market opens in 10h 58m

PT Kalbe Farma Tbk. (PTKFY) Stock Competitors & Peer Comparison

See (PTKFY) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
PTKFY$10.49-4.18%11.9M11.16$0.94+4.21%
BMYMP$400.00-57.46%814.6B1777.78$0.23+4.26%
RHHBF$419.50-3.55%346.2B21.21$20.51+2.93%
RHHBY$51.75-0.21%332.8B20.19$2.56+3.08%
RHHVF$403.29+8.69%321B19.92$20.25+3.09%
AZNCF$189.90-1.35%294.4B31.49$6.03+1.41%
NVSEF$145.00-0.02%276.7B20.31$7.14+3.28%
SNYNF$92.44+0.00%110.9B19.88$4.65+4.74%
GLAXF$27.21+0.00%108.7B14.55$1.87+3.24%
CHGCY$27.22-2.37%89.9B32.92$0.83+3.01%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

PTKFY vs BMYMP Comparison April 2026

PTKFY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PTKFY stands at 11.9M. In comparison, BMYMP has a market cap of 814.6B. Regarding current trading prices, PTKFY is priced at $10.49, while BMYMP trades at $400.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PTKFY currently has a P/E ratio of 11.16, whereas BMYMP's P/E ratio is 1777.78. In terms of profitability, PTKFY's ROE is +0.16%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, PTKFY is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for PTKFY.Check BMYMP's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions